Skip to main content

It looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.

Switch to US ($)
Contact +33 (0)3 90 20 54 70

🚀 Special Offer🚀Get 25% off on your bioreagent online order (except Micelles and Nanodiscs), with the code: PROTEOSHOP25

📢 New ! Accelerate your Antibody Development with Ready-to-use Stable Cell Pools

Explore Now
  • Wide range of unique reagents
  • Free Shipping
    Free shipping in EU on Orders > €500
  • Fast worldwide delivery
    Fast worldwide delivery
Nycodenz AG® Nycodenz AG® XtenCHO ™ Race Starter kit XtenCHO ™ Race Starter kit
View all Products

Blinatumomab Biosimilar – Anti-CD19, CD3E mAb – Research Grade

Reference:
Size

100ug, 1MG
Isotype

(scFv-kappa-heavy)-(scFv-heavy-kappa); His-Tag
Brand

ProteoGenix
Product type

Primary Antibodies
Clonality

Monoclonal Antibody
Expression system

Mammalian cells
Applications

Elisa, WB
Tags:
Specification
Description
Documents
Publications
Reviews
Product nameBlinatumomab Biosimilar - Anti-CD19, CD3E mAb - Research Grade
SourceCAS 853426-35-4
SpeciesMus musculus
Expression systemMammalian
Molecular weight54.1kDa
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery lead time in business days3-5 days if in stock; 3-5 weeks if production needed
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsBlinatumomab,AMG103,BITE MT-103,MEDI-538,MT103,bscCD19xCD3,CD19, CD3E,anti-CD19, CD3E
ReferencePX-TA1067
NoteFor research use only. Not suitable for human use.
Isotype(scFv-kappa-heavy)-(scFv-heavy-kappa); His-Tag
ClonalityMonoclonal Antibody

Description of Blinatumomab Biosimilar - Anti-CD19, CD3E mAb - Research Grade

General information on Anti-CD19/CD3E(Homo sapiens) (Blinatumomab) Monoclonal Antibody

Blinatumomab is a monoclonal antibody constructed by BiTE (bispecific T cell engagers), which is used to treat relapsed or refractory B cell precursor acute lymphoblastic leukemia (ALL) with negative Philadelphia chromosome. Blinatumomab is available as a drug under the Blincyto™ brand.

Datasheet Download
MSDS Download

Publication

Park AK, Monroy I, Ren Y, Lu C, Chaurasiya S, Valencia H, et al. Universal off-the-shelf combination immunotherapy using oncolytic viruses to redirect T cell engagers to target solid tumors. Journal for ImmunoTherapy of Cancer. 2025;13:e011051. https://doi.org/10.1136/jitc-2024-011051

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Blinatumomab Biosimilar – Anti-CD19, CD3E mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

CD19 Protein – Human CD19 recombinant protein
Antigen

CD19 Protein – Human CD19 recombinant protein

PX-P4004 210€
View product
CD3E Recombinant Protein
Antigen

CD3E Recombinant Protein

PX-P4075 420€
View product
CD19 Recombinant Protein
Antigen

CD19 Recombinant Protein

PX-P4077 420€
View product

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.

    Cart (0 Items)

    Your cart is currently empty.

    View Products